Avanir Pharmaceuticals Completes Sale Of FazaClo

Avanir Pharmaceuticals announced that it has completed the sale of currently marketed, antipsychotic drug FazaClo (clozapine, USP) to Azur Pharma, a specialty pharmaceutical company headquartered in Ireland.
Avanir